The LDL receptor is the major pathway for beta-VLDL uptake by mouse peritoneal macrophages

Area of Science:

• Biochemistry
• Immunology
• Cardiovascular Research

Background:

• Macrophages play a key role in lipoprotein metabolism and atherosclerosis.
• The low-density lipoprotein receptor (LDL-R) is a primary mediator of cellular cholesterol uptake.
• Understanding lipoprotein uptake mechanisms by macrophages is vital for cardiovascular disease research.

Purpose of the Study:

• To investigate the role of the LDL-R in the uptake and degradation of native, apoB-containing lipoproteins by macrophages.
• To compare lipoprotein handling in macrophages from wild-type versus LDL-R deficient mice.

Main Methods:

• Peritoneal macrophages (MPM) were isolated from wild-type and LDL-R deficient mice.
• Uptake and degradation assays were performed using beta-very low-density lipoproteins (beta-VLDL) isolated from apoE-deficient or LDL-R deficient mice fed a high-fat diet.
• Cholesteryl ester (CE) formation in macrophages was measured.
• Competition assays with unlabeled human LDL and apoE-containing or apoE-deficient beta-VLDL were conducted.

Main Results:

• Macrophages poorly degraded lipoproteins from apoE-deficient mice, irrespective of LDL-R presence.
• Macrophages from wild-type mice avidly took up apoE-containing beta-VLDL from LDL-R deficient mice, leading to significant CE formation.
• Macrophages lacking LDL-R did not show this avid uptake or CE formation.
• Degradation of 125I-labeled apoE-containing beta-VLDL by wild-type MPM was minimally inhibited by unlabeled LDL and unaffected by apoE-deficient beta-VLDL.

Conclusions:

• The LDL-R is the primary receptor mediating the in vitro uptake of native apoE-enriched lipoproteins by murine macrophages.
• Other apoE-recognizing receptor systems, including LDL receptor-related protein, VLDL receptor, and scavenger receptor class B type I, do not significantly contribute to this uptake pathway.
• These findings highlight the critical role of LDL-R in macrophage lipoprotein processing and suggest potential therapeutic targets for atherosclerosis.